Actions

MDMA: Difference between revisions

An Avatar.Global Resource

m Text replacement - "{{template:connectionnav}}" to "<!-- connectionnav -->"
No edit summary
Line 1: Line 1:
<!-- connectionnav -->
{{template:draft}}
{{navmenu}}
{{navmenu}}
<h1 class="customtitle">{{FULLPAGENAME}}</h1>
<h1 class="customtitle">{{FULLPAGENAME}}</h1>
Line 15: Line 11:
==Notes==
==Notes==


{{template:cite}}
MDMA a "breakthrough" therapy for PTSD.<ref>Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.</ref>
 
==Footnotes==


<references />
{{endstuff}}


{{template:references}}


[[category:terms]][[Is a::Connection Supplement| ]]
[[category:terms]][[category:lightningpath]][[Is a::Connection Supplement| ]]

Revision as of 17:03, 9 December 2021

MDMA

List of Connection Supplements

Connection Supplement > 5-MEO DMT, Ayahuasca, Cannabis, Chloroform, DMT, Datura, Haoma, Kaneh Bosm, Kava, Ketamine, Kykeon, LSD, MDMA, Maikua, Manna, Nitrous Oxide, Peyote, Psilocybin Mushroom, Santa Rosa, Soma, Tobacco, Yaqona

Notes

MDMA a "breakthrough" therapy for PTSD.[1]

Citation and Legal

The SpiritWiki is a freely available, open-access Knowledge System devoted to health, healing, and reconnection. You may freely use information in the SpiritWiki; citation and attribution are welcomed, but not required. You can help this knowledge system grow by joining its Patreon.

The SpiritWiki is marked CC0 1.0 Universal and in the public domain, free for everyone on the planet to use. Please support its growth.

Footnotes

  1. Mitchell, Jennifer M., Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman, Kelly Parker-Guilbert, Marcela Ot’alora G., et al. “MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.” Nature Medicine 27, no. 6 (June 1, 2021): 1025–33. https://doi.org/10.1038/s41591-021-01336-3.